These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26307155)

  • 21. Most ten-year-old children with negative or unknown histories of chickenpox are immune.
    Boulianne N; Duval B; De Serres G; Deceuninck G; Massé R; Couillard M
    Pediatr Infect Dis J; 2001 Nov; 20(11):1087-8. PubMed ID: 11734718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of varicella-zoster virus infection among Thai healthcare workers.
    Apisarnthanarak A; Kitphati R; Tawatsupha P; Thongphubeth K; Apisarnthanarak P; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):430-4. PubMed ID: 17385149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella Zoster antibodies among health care workers in a university hospital, Teheran, Iran.
    Talebi-Taher M; Noori M; Shamshiri AR; Barati M
    Int J Occup Med Environ Health; 2010; 23(1):27-32. PubMed ID: 20442060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Varicella-zoster infections: zoster immune globulin.
    Hussey HH
    JAMA; 1974 May; 228(7):876. PubMed ID: 4362716
    [No Abstract]   [Full Text] [Related]  

  • 26. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to varicella-zoster virus in a normal adult population.
    Ndumbe PM; Macqueen S; Holzel H; Levinsky RJ
    J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.
    Waclawski ER; Stewart M
    Commun Dis Public Health; 2002 Sep; 5(3):240-2. PubMed ID: 12434695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroepidemiology of Varicella and value of self-reported history of Varicella infection in Iranian medical students.
    Allami A; Mohammadi N; Najar A
    Int J Occup Med Environ Health; 2014 Apr; 27(2):304-13. PubMed ID: 24715422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The epidemiologic significance of varicella].
    Hofmann F; Sydow B; Michaelis M
    Gesundheitswesen; 1994 Nov; 56(11):599-601. PubMed ID: 7819671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of antibody to varicella-zoster virus in systemic lupus erythematosus.
    Nagasawa K; Yamauchi Y; Tada Y; Tsukamoto H; Mayumi T; Niho Y
    J Infect Dis; 1992 Sep; 166(3):692-4. PubMed ID: 1323629
    [No Abstract]   [Full Text] [Related]  

  • 34. Susceptibility to varicella virus of certain adults in the southeastern United States.
    Hyams PJ; Vernon S; Eckert D
    Am J Infect Control; 1984 Feb; 12(1):6-9. PubMed ID: 6322621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of a history of previous varicella infection in adults.
    Wallace MR; Chamberlin CJ; Zerboni L; Sawyer MH; Oldfield EC; Olson PE; Arvin AM
    JAMA; 1997 Nov; 278(18):1520-2. PubMed ID: 9363973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization: varicella-zoster vaccine.
    Heim LR
    Cutis; 1979 Feb; 23(2):144, 146-7, 152. PubMed ID: 217569
    [No Abstract]   [Full Text] [Related]  

  • 38. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's new in chickenpox (varicella-zoster) infection?
    Gershon AA
    West J Med; 1993 Feb; 158(2):180. PubMed ID: 8382001
    [No Abstract]   [Full Text] [Related]  

  • 40. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.